Page last updated: 2024-09-04

levofloxacin and 4-(3-(2-nitro-1-imidazolyl)-propylamino)-7-chloroquinoline hydrochloride

levofloxacin has been researched along with 4-(3-(2-nitro-1-imidazolyl)-propylamino)-7-chloroquinoline hydrochloride in 1 studies

Compound Research Comparison

Studies
(levofloxacin)
Trials
(levofloxacin)
Recent Studies (post-2010)
(levofloxacin)
Studies
(4-(3-(2-nitro-1-imidazolyl)-propylamino)-7-chloroquinoline hydrochloride)
Trials
(4-(3-(2-nitro-1-imidazolyl)-propylamino)-7-chloroquinoline hydrochloride)
Recent Studies (post-2010) (4-(3-(2-nitro-1-imidazolyl)-propylamino)-7-chloroquinoline hydrochloride)
4,3465812,2092403

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bloomer, WD; Kaiser, M; Papadopoulou, MV; Rosenzweig, HS1

Other Studies

1 other study(ies) available for levofloxacin and 4-(3-(2-nitro-1-imidazolyl)-propylamino)-7-chloroquinoline hydrochloride

ArticleYear
The antitrypanosomal and antitubercular activity of some nitro(triazole/imidazole)-based aromatic amines.
    European journal of medicinal chemistry, 2017, Sep-29, Volume: 138

    Topics: Amines; Antitubercular Agents; Dose-Response Relationship, Drug; Imidazoles; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nitro Compounds; Parasitic Sensitivity Tests; Structure-Activity Relationship; Triazoles; Trypanocidal Agents; Trypanosoma brucei rhodesiense; Trypanosoma cruzi

2017